Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy
- PMID: 22220321
- Bookshelf ID: NBK62652
Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy
Excerpt
This guideline was partially updated in June 2019.
This clinical guideline concerns the management of hypertensive disorders in pregnancy and their complications from preconception to the postnatal period. For the purpose of this guideline, ‘pregnancy’ includes the antenatal, intrapartum and postpartum (6 weeks after birth) periods. The guideline has been developed with the aim of providing guidance in the following areas: information and advice for women who have chronic hypertension and are pregnant or planning to become pregnant; information and advice for women who are pregnant and at increased risk of developing hypertensive disorders of pregnancy; management of pregnancy with chronic hypertension; management of pregnancy in women with gestational hypertension; management of pregnancy for women with pre-eclampsia before admission to critical care level 2 setting; management of pre-eclampsia and its complications in a critical care setting; information, advice and support for women and healthcare professionals after discharge to primary care following a pregnancy complicated by hypertension; care of the fetus during pregnancy complicated by a hypertensive disorder.
Copyright © 2011, Royal College of Obstetricians and Gynaecologists.
Sections
- Guideline development group membership and acknowledgements
- 1. Summary of recommendations and care pathway
- 2. Development of the guideline
- 3. Reducing the risk of hypertensive disorders in pregnancy
- 4. Management of pregnancy with chronic hypertension
- 5. Assessment of proteinuria in hypertensive disorders of pregnancy
- 6. Management of pregnancy with gestational hypertension
- 7. Management of pregnancy with pre-eclampsia
- 8. Fetal monitoring
- 9. Intrapartum care
- 10. Medical management of severe hypertension or severe pre-eclampsia in a critical care setting
- 11. Breastfeeding
- 12. Advice and follow-up care at transfer to community care
- 13. References, abbreviations and glossary
- Appendix A. Scope of the guideline
- Appendix B. Declarations of interest
- Appendix C. Registered stakeholder organisations
- Appendix D. Clinical questions
- Appendix E. Search strategies
- Appendix F. Excluded studies
- Appendix G. Evidence tables
- Appendix H. Cost effectiveness of aspirin compared with no aspirin in preventing pre-eclampsia in women at risk of developing pre-eclampsia
- Appendix I. Economic analysis of immediate birth (induction of labour) versus expectant management in women with mild to moderate gestational hypertension after 37 weeks of gestation
- Appendix J. Economic analysis of immediate birth (induction of labour) versus expectant management in women who have pre-eclampsia with mild or moderate hypertension at 34–37 weeks of gestation
- Appendix K. Cost effectiveness of using a 1+ dipstick urinalysis threshold versus a 2+ dipstick urinalysis threshold in screening for proteinuria in women with gestational hypertension
- Appendix L. Cost effectiveness of automated urinalysis compared with visual urinalysis in screening for proteinuria in women with gestational hypertension
- Appendix M. Cost effectiveness of quantifying proteinuria in women with gestational hypertension
- Appendix N. Safety data for antihypertensives in pregnancy
- Appendix O. Safety of commonly used antihypertensive drugs during breastfeeding
Publication types
LinkOut - more resources
Full Text Sources
Medical